Drug Database
Back to search

Netherlands· NL-89893f290091

Carteabak 1%, oogdruppels,oplossing

A carteolol product containing carteololhydrochloride, registered in Netherlands by Laboratoires Théa. The same ATC class is registered in 8 of our 19 countries.

ATC S01ED05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCarteabak 1%, oogdruppels,oplossingATCS01ED05REGISTER NO.NL-89893f290091PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about carteololhydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Carteolol is registered in 8 of 19 countries.

Countries holding a registration under ATC S01ED05 (carteolol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search carteolol products by name

Carteolol · ATC S01ED05

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CARTEOLOLHYDROCHLORIDE
Manufacturer
Laboratoires Théa
Country
Netherlands (NL)
ATC code
S01ED05
ATC class
Carteolol
Defined daily dose
0.2 ml, AT
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    29949

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

97 interactions on record for carteolol.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check carteolol against other medicinesHow interaction checks work

Carteolol · interactions on record

97 records

  • 28 severe
  • 67 moderate
  • 2 minor

Most severe, free to view

  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • OrciprenalinC01CA29severe
  • TheophyllinC01EB28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Carteolol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carteolol products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Arteoptic La, Arteoptic La Sine Conservans
  • Czechia · Carteol Lp, Carteol Neo
  • Spain · Arteoptic, Arteoptic Pf
  • France · Carteol, Carteol L.P.
  • Croatia · Cartelomb
  • Italy · Carteabak, Carteol
  • Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
  • Poland · Carteol Lp, Carteol Lp Preservative Free
  • Portugal · Physioglau, Physioglau Pf
  • Slovenia · Cartelomb
  • Slovakia · Carteol Lp, Carteol Neo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd1c6be3-8785-47e7-adc4-83bcbb9717b6
GET /v1/drugs/cd1c6be3-8785-47e7-adc4-83bcbb9717b6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h29949_smpc.pdf",
  "strength": null,
  "atc_label": "Carteolol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29949",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "CARTEOLOLHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29949.pdf",
  "authorised_at": "2004/08/26",
  "procedure_number": "NL/H/3077/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "29949",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about carteolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console